Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,801 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of the Xanthine Oxidase Inhibitor, Febuxostat, on WBC Count in Asymptomatic Hyperuricemia: Subanalysis of the Randomized PRIZE Study.
Takeshita M, Tanaka A, Yoshida H, Nakamura I, Shibata Y, Hata S, Kushiyama A, Okutsu M, Ishizu T, Node K. Takeshita M, et al. Among authors: shibata y. J Atheroscler Thromb. 2024 Jun 1;31(6):864-875. doi: 10.5551/jat.64574. Epub 2024 Jan 13. J Atheroscler Thromb. 2024. PMID: 38220209 Free PMC article. Clinical Trial.
Acute effects of statin on reduction of angiopoietin-like 2 and glyceraldehyde-derived advanced glycation end-products levels in patients with acute myocardial infarction: a message from SAMIT (Statin for Acute Myocardial Infarction Trial).
Shimomura M, Oyama J, Takeuchi M, Shibata Y, Yamamoto Y, Kawasaki T, Komoda H, Kodama K, Sakuma M, Toyoda S, Inoue Y, Mine D, Natsuaki M, Komatsu A, Hikichi Y, Yamagishi S, Inoue T, Node K. Shimomura M, et al. Among authors: shibata y. Heart Vessels. 2016 Oct;31(10):1583-9. doi: 10.1007/s00380-015-0773-y. Epub 2015 Dec 23. Heart Vessels. 2016. PMID: 26699899 Clinical Trial.
α-Glucosidase inhibitor miglitol attenuates glucose fluctuation, heart rate variability and sympathetic activity in patients with type 2 diabetes and acute coronary syndrome: a multicenter randomized controlled (MACS) study.
Shimabukuro M, Tanaka A, Sata M, Dai K, Shibata Y, Inoue Y, Ikenaga H, Kishimoto S, Ogasawara K, Takashima A, Niki T, Arasaki O, Oshiro K, Mori Y, Ishihara M, Node K; Collaborators on the Effect of Miglitol on Glucose Metabolism in Acute Coronary Syndrome (MACS) Study. Shimabukuro M, et al. Among authors: shibata y. Cardiovasc Diabetol. 2017 Jul 6;16(1):86. doi: 10.1186/s12933-017-0571-1. Cardiovasc Diabetol. 2017. PMID: 28683829 Free PMC article. Clinical Trial.
Effect of pioglitazone on cardiometabolic profiles and safety in patients with type 2 diabetes undergoing percutaneous coronary artery intervention: a prospective, multicenter, randomized trial.
Tanaka A, Komukai S, Shibata Y, Yokoi H, Iwasaki Y, Kawasaki T, Horiuchi K, Nakao K, Ueno T, Nakashima H, Tamashiro M, Hikichi Y, Shimomura M, Tago M, Toyoda S, Inoue T, Kawaguchi A, Node K; Pioglitazone Reduce Inflammation and Restenosis with and without Drug Eluting Stent (PRIDE) Study Investigators. Tanaka A, et al. Among authors: shibata y. Heart Vessels. 2018 Sep;33(9):965-977. doi: 10.1007/s00380-018-1143-3. Epub 2018 Feb 27. Heart Vessels. 2018. PMID: 29487991 Clinical Trial.
Sitagliptin on carotid intima-media thickness in type 2 diabetes patients receiving primary or secondary prevention of cardiovascular disease: A subgroup analysis of the PROLOGUE study.
Tanaka A, Yoshida H, Nanasato M, Oyama JI, Ishizu T, Ajioka M, Ishiki R, Saito M, Shibata Y, Kaku K, Maemura K, Higashi Y, Inoue T, Murohara T, Node K. Tanaka A, et al. Among authors: shibata y. Int J Cardiol. 2018 Nov 15;271:331-335. doi: 10.1016/j.ijcard.2018.05.055. Epub 2018 May 19. Int J Cardiol. 2018. PMID: 29803341 Clinical Trial.
2,801 results